Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
2 other identifiers
observational
23
1 country
1
Brief Summary
Background: Many bacteria live in the gut. The gut is the tube that moves food from the mouth through the stomach to the intestines. Heavy alcohol use disturbs these bacteria. There is evidence that the bacteria in the gut may affect anxiety and depression. Researchers want to learn more about these bacteria in order to better treat diseases such as alcohol dependence. Objective: To identify the different bacteria that live in the mouth and gut. Also, to learn if these bacteria change as a person goes through alcohol detoxification. Eligibility: People ages 18 and older who:
- Enrolled in screening protocol 14-AA-0181
- Are going through detoxification treatment at the Clinical Center Design: Participants will have physical exams. Participants will answer questions about:
- Anxiety and depression
- Alcohol use
- Sleep
- Abdominal and oral health
- Diet Participants will keep a regular record of their diet. Participants will have breath alcohol analysis 4 times per day. Participants will provide stool and oral specimens at most once a day for the first week. Then, they will provide them once a week while they are at the Clinical Center.
- For the oral specimen: A small brush rubs the tongue. They may not eat, drink, or perform oral care within 2 hours of collection.
- For the stool specimen: They will receive a container that fits in the toilet. They will let the nurse know right away when the sample is ready. Participants will have a dental visit. This consists of an oral exam and oral health assessment. The dentist may recommend a cleaning or dental X-rays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2016
CompletedFirst Posted
Study publicly available on registry
September 22, 2016
CompletedStudy Start
First participant enrolled
September 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 29, 2017
CompletedMay 1, 2026
January 16, 2026
11 months
September 21, 2016
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of bacteria in the gut and oral microbiomes over time
Characterization of the gut and oral micro biome
all timepoints
Study Arms (1)
AUD population
The participants/group were treatment-seeking AUD individuals admitted to the NIH CC 1SE Addictions Unit.
Eligibility Criteria
inpatient treatment seeking alcohol dependent participants
You may qualify if:
- At least 18 years of age
- Willing to provide consent
- Consented on screening and research protocol 14-AA-0181
- Admitted to the NIH CC for inpatient detoxification treatment
You may not qualify if:
- Currently using or have used any of the following drugs within the last month by self-report:
- Antibiotics
- Corticosteroids: inhaled, oral, intravenous or intramuscular
- Immunosuppressive or cytotoxic agents
- Large doses of probiotics such as supplemental probiotics (ordinary dietary components such as beverages/milk or yogurt DO NOT APPLY)
- Any bowel resection at any time.
- History of active uncontrolled gastrointestinal disorders or diseases including inflammatory bowel disease, ulcerative colitis, Crohn s disease, and/or infectious gastroenteritis, colitis, or gastritis (per patient s report of whether or not they have been diagnosed by a physician).
- Enrolled in any investigational study that might affect the microbiome.
- BMI greater than or equal to 30 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine A Maki, C.R.N.P.
National Institutes of Health Clinical Center (CC)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2016
First Posted
September 22, 2016
Study Start
September 27, 2016
Primary Completion
August 29, 2017
Study Completion
August 29, 2017
Last Updated
May 1, 2026
Record last verified: 2026-01-16